Ambrisentan Drug Market Report

Global Ambrisentan Drug Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 08, 2022
  • PAGES：170
  • REPORT CODE：GMM848257
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Ambrisentan (U.S. trade name Letairis; E.U. trade name Volibris; India trade name Pulmonext by MSN labs) is a drug indicated for use in the treatment of pulmonary hypertension.

    Ambrisentan Drug market report explains the definition, types, applications, major countries, and major players of the Ambrisentan Drug market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Sigmapharm Laboratories, LLC (United States)

    • Cipla Inc (India)

    • Glaxo Smith Kline Limited (United Kingdom)

    • Par Pharmaceutical, Inc (United States)

    • Gilead Sciences, Inc (United States)

    • Mylan SAS (United States)

    By Type:

    • 5 mg Tablet

    • 10 mg Tablet

    By End-User:

    • Hospital

    • Drug store

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Ambrisentan Drug Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Ambrisentan Drug Outlook to 2028- Original Forecasts

    • 2.2 Ambrisentan Drug Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Ambrisentan Drug Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Ambrisentan Drug Market- Recent Developments

    • 6.1 Ambrisentan Drug Market News and Developments

    • 6.2 Ambrisentan Drug Market Deals Landscape

    7 Ambrisentan Drug Raw Materials and Cost Structure Analysis

    • 7.1 Ambrisentan Drug Key Raw Materials

    • 7.2 Ambrisentan Drug Price Trend of Key Raw Materials

    • 7.3 Ambrisentan Drug Key Suppliers of Raw Materials

    • 7.4 Ambrisentan Drug Market Concentration Rate of Raw Materials

    • 7.5 Ambrisentan Drug Cost Structure Analysis

      • 7.5.1 Ambrisentan Drug Raw Materials Analysis

      • 7.5.2 Ambrisentan Drug Labor Cost Analysis

      • 7.5.3 Ambrisentan Drug Manufacturing Expenses Analysis

    8 Global Ambrisentan Drug Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Ambrisentan Drug Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Ambrisentan Drug Export by Region (Top 10 Countries) (2017-2028)

    9 Global Ambrisentan Drug Market Outlook by Types and Applications to 2022

    • 9.1 Global Ambrisentan Drug Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global 5 mg Tablet Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global 10 mg Tablet Consumption and Growth Rate (2017-2022)

    • 9.2 Global Ambrisentan Drug Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Drug store Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Ambrisentan Drug Market Analysis and Outlook till 2022

    • 10.1 Global Ambrisentan Drug Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Ambrisentan Drug Consumption (2017-2022)

      • 10.2.2 Canada Ambrisentan Drug Consumption (2017-2022)

      • 10.2.3 Mexico Ambrisentan Drug Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Ambrisentan Drug Consumption (2017-2022)

      • 10.3.2 UK Ambrisentan Drug Consumption (2017-2022)

      • 10.3.3 Spain Ambrisentan Drug Consumption (2017-2022)

      • 10.3.4 Belgium Ambrisentan Drug Consumption (2017-2022)

      • 10.3.5 France Ambrisentan Drug Consumption (2017-2022)

      • 10.3.6 Italy Ambrisentan Drug Consumption (2017-2022)

      • 10.3.7 Denmark Ambrisentan Drug Consumption (2017-2022)

      • 10.3.8 Finland Ambrisentan Drug Consumption (2017-2022)

      • 10.3.9 Norway Ambrisentan Drug Consumption (2017-2022)

      • 10.3.10 Sweden Ambrisentan Drug Consumption (2017-2022)

      • 10.3.11 Poland Ambrisentan Drug Consumption (2017-2022)

      • 10.3.12 Russia Ambrisentan Drug Consumption (2017-2022)

      • 10.3.13 Turkey Ambrisentan Drug Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Ambrisentan Drug Consumption (2017-2022)

      • 10.4.2 Japan Ambrisentan Drug Consumption (2017-2022)

      • 10.4.3 India Ambrisentan Drug Consumption (2017-2022)

      • 10.4.4 South Korea Ambrisentan Drug Consumption (2017-2022)

      • 10.4.5 Pakistan Ambrisentan Drug Consumption (2017-2022)

      • 10.4.6 Bangladesh Ambrisentan Drug Consumption (2017-2022)

      • 10.4.7 Indonesia Ambrisentan Drug Consumption (2017-2022)

      • 10.4.8 Thailand Ambrisentan Drug Consumption (2017-2022)

      • 10.4.9 Singapore Ambrisentan Drug Consumption (2017-2022)

      • 10.4.10 Malaysia Ambrisentan Drug Consumption (2017-2022)

      • 10.4.11 Philippines Ambrisentan Drug Consumption (2017-2022)

      • 10.4.12 Vietnam Ambrisentan Drug Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Ambrisentan Drug Consumption (2017-2022)

      • 10.5.2 Colombia Ambrisentan Drug Consumption (2017-2022)

      • 10.5.3 Chile Ambrisentan Drug Consumption (2017-2022)

      • 10.5.4 Argentina Ambrisentan Drug Consumption (2017-2022)

      • 10.5.5 Venezuela Ambrisentan Drug Consumption (2017-2022)

      • 10.5.6 Peru Ambrisentan Drug Consumption (2017-2022)

      • 10.5.7 Puerto Rico Ambrisentan Drug Consumption (2017-2022)

      • 10.5.8 Ecuador Ambrisentan Drug Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Ambrisentan Drug Consumption (2017-2022)

      • 10.6.2 Kuwait Ambrisentan Drug Consumption (2017-2022)

      • 10.6.3 Oman Ambrisentan Drug Consumption (2017-2022)

      • 10.6.4 Qatar Ambrisentan Drug Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Ambrisentan Drug Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Ambrisentan Drug Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Ambrisentan Drug Consumption (2017-2022)

      • 10.7.2 South Africa Ambrisentan Drug Consumption (2017-2022)

      • 10.7.3 Egypt Ambrisentan Drug Consumption (2017-2022)

      • 10.7.4 Algeria Ambrisentan Drug Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Ambrisentan Drug Consumption (2017-2022)

      • 10.8.2 New Zealand Ambrisentan Drug Consumption (2017-2022)

    11 Global Ambrisentan Drug Competitive Analysis

    • 11.1 Sigmapharm Laboratories, LLC (United States)

      • 11.1.1 Sigmapharm Laboratories, LLC (United States) Company Details

      • 11.1.2 Sigmapharm Laboratories, LLC (United States) Ambrisentan Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Sigmapharm Laboratories, LLC (United States) Ambrisentan Drug Main Business and Markets Served

      • 11.1.4 Sigmapharm Laboratories, LLC (United States) Ambrisentan Drug Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Cipla Inc (India)

      • 11.2.1 Cipla Inc (India) Company Details

      • 11.2.2 Cipla Inc (India) Ambrisentan Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Cipla Inc (India) Ambrisentan Drug Main Business and Markets Served

      • 11.2.4 Cipla Inc (India) Ambrisentan Drug Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Glaxo Smith Kline Limited (United Kingdom)

      • 11.3.1 Glaxo Smith Kline Limited (United Kingdom) Company Details

      • 11.3.2 Glaxo Smith Kline Limited (United Kingdom) Ambrisentan Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Glaxo Smith Kline Limited (United Kingdom) Ambrisentan Drug Main Business and Markets Served

      • 11.3.4 Glaxo Smith Kline Limited (United Kingdom) Ambrisentan Drug Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Par Pharmaceutical, Inc (United States)

      • 11.4.1 Par Pharmaceutical, Inc (United States) Company Details

      • 11.4.2 Par Pharmaceutical, Inc (United States) Ambrisentan Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Par Pharmaceutical, Inc (United States) Ambrisentan Drug Main Business and Markets Served

      • 11.4.4 Par Pharmaceutical, Inc (United States) Ambrisentan Drug Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Gilead Sciences, Inc (United States)

      • 11.5.1 Gilead Sciences, Inc (United States) Company Details

      • 11.5.2 Gilead Sciences, Inc (United States) Ambrisentan Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Gilead Sciences, Inc (United States) Ambrisentan Drug Main Business and Markets Served

      • 11.5.4 Gilead Sciences, Inc (United States) Ambrisentan Drug Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Mylan SAS (United States)

      • 11.6.1 Mylan SAS (United States) Company Details

      • 11.6.2 Mylan SAS (United States) Ambrisentan Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Mylan SAS (United States) Ambrisentan Drug Main Business and Markets Served

      • 11.6.4 Mylan SAS (United States) Ambrisentan Drug Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    12 Global Ambrisentan Drug Market Outlook by Types and Applications to 2028

    • 12.1 Global Ambrisentan Drug Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global 5 mg Tablet Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global 10 mg Tablet Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Ambrisentan Drug Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Drug store Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Ambrisentan Drug Market Analysis and Outlook to 2028

    • 13.1 Global Ambrisentan Drug Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Ambrisentan Drug Consumption Forecast (2022-2028)

      • 13.2.2 Canada Ambrisentan Drug Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Ambrisentan Drug Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Ambrisentan Drug Consumption Forecast (2022-2028)

      • 13.3.2 UK Ambrisentan Drug Consumption Forecast (2022-2028)

      • 13.3.3 Spain Ambrisentan Drug Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Ambrisentan Drug Consumption Forecast (2022-2028)

      • 13.3.5 France Ambrisentan Drug Consumption Forecast (2022-2028)

      • 13.3.6 Italy Ambrisentan Drug Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Ambrisentan Drug Consumption Forecast (2022-2028)

      • 13.3.8 Finland Ambrisentan Drug Consumption Forecast (2022-2028)

      • 13.3.9 Norway Ambrisentan Drug Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Ambrisentan Drug Consumption Forecast (2022-2028)

      • 13.3.11 Poland Ambrisentan Drug Consumption Forecast (2022-2028)

      • 13.3.12 Russia Ambrisentan Drug Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Ambrisentan Drug Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Ambrisentan Drug Consumption Forecast (2022-2028)

      • 13.4.2 Japan Ambrisentan Drug Consumption Forecast (2022-2028)

      • 13.4.3 India Ambrisentan Drug Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Ambrisentan Drug Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Ambrisentan Drug Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Ambrisentan Drug Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Ambrisentan Drug Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Ambrisentan Drug Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Ambrisentan Drug Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Ambrisentan Drug Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Ambrisentan Drug Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Ambrisentan Drug Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Ambrisentan Drug Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Ambrisentan Drug Consumption Forecast (2022-2028)

      • 13.5.3 Chile Ambrisentan Drug Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Ambrisentan Drug Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Ambrisentan Drug Consumption Forecast (2022-2028)

      • 13.5.6 Peru Ambrisentan Drug Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Ambrisentan Drug Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Ambrisentan Drug Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Ambrisentan Drug Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Ambrisentan Drug Consumption Forecast (2022-2028)

      • 13.6.3 Oman Ambrisentan Drug Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Ambrisentan Drug Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Ambrisentan Drug Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Ambrisentan Drug Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Ambrisentan Drug Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Ambrisentan Drug Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Ambrisentan Drug Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Ambrisentan Drug Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Ambrisentan Drug Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Ambrisentan Drug Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Ambrisentan Drug

    • Figure of Ambrisentan Drug Picture

    • Table Global Ambrisentan Drug Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Ambrisentan Drug Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global 5 mg Tablet Consumption and Growth Rate (2017-2022)

    • Figure Global 10 mg Tablet Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Drug store Consumption and Growth Rate (2017-2022)

    • Figure Global Ambrisentan Drug Consumption by Country (2017-2022)

    • Table North America Ambrisentan Drug Consumption by Country (2017-2022)

    • Figure United States Ambrisentan Drug Consumption and Growth Rate (2017-2022)

    • Figure Canada Ambrisentan Drug Consumption and Growth Rate (2017-2022)

    • Figure Mexico Ambrisentan Drug Consumption and Growth Rate (2017-2022)

    • Table Europe Ambrisentan Drug Consumption by Country (2017-2022)

    • Figure Germany Ambrisentan Drug Consumption and Growth Rate (2017-2022)

    • Figure UK Ambrisentan Drug Consumption and Growth Rate (2017-2022)

    • Figure Spain Ambrisentan Drug Consumption and Growth Rate (2017-2022)

    • Figure Belgium Ambrisentan Drug Consumption and Growth Rate (2017-2022)

    • Figure France Ambrisentan Drug Consumption and Growth Rate (2017-2022)

    • Figure Italy Ambrisentan Drug Consumption and Growth Rate (2017-2022)

    • Figure Denmark Ambrisentan Drug Consumption and Growth Rate (2017-2022)

    • Figure Finland Ambrisentan Drug Consumption and Growth Rate (2017-2022)

    • Figure Norway Ambrisentan Drug Consumption and Growth Rate (2017-2022)

    • Figure Sweden Ambrisentan Drug Consumption and Growth Rate (2017-2022)

    • Figure Poland Ambrisentan Drug Consumption and Growth Rate (2017-2022)

    • Figure Russia Ambrisentan Drug Consumption and Growth Rate (2017-2022)

    • Figure Turkey Ambrisentan Drug Consumption and Growth Rate (2017-2022)

    • Table APAC Ambrisentan Drug Consumption by Country (2017-2022)

    • Figure China Ambrisentan Drug Consumption and Growth Rate (2017-2022)

    • Figure Japan Ambrisentan Drug Consumption and Growth Rate (2017-2022)

    • Figure India Ambrisentan Drug Consumption and Growth Rate (2017-2022)

    • Figure South Korea Ambrisentan Drug Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Ambrisentan Drug Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Ambrisentan Drug Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Ambrisentan Drug Consumption and Growth Rate (2017-2022)

    • Figure Thailand Ambrisentan Drug Consumption and Growth Rate (2017-2022)

    • Figure Singapore Ambrisentan Drug Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Ambrisentan Drug Consumption and Growth Rate (2017-2022)

    • Figure Philippines Ambrisentan Drug Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Ambrisentan Drug Consumption and Growth Rate (2017-2022)

    • Table South America Ambrisentan Drug Consumption by Country (2017-2022)

    • Figure Brazil Ambrisentan Drug Consumption and Growth Rate (2017-2022)

    • Figure Colombia Ambrisentan Drug Consumption and Growth Rate (2017-2022)

    • Figure Chile Ambrisentan Drug Consumption and Growth Rate (2017-2022)

    • Figure Argentina Ambrisentan Drug Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Ambrisentan Drug Consumption and Growth Rate (2017-2022)

    • Figure Peru Ambrisentan Drug Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Ambrisentan Drug Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Ambrisentan Drug Consumption and Growth Rate (2017-2022)

    • Table GCC Ambrisentan Drug Consumption by Country (2017-2022)

    • Figure Bahrain Ambrisentan Drug Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Ambrisentan Drug Consumption and Growth Rate (2017-2022)

    • Figure Oman Ambrisentan Drug Consumption and Growth Rate (2017-2022)

    • Figure Qatar Ambrisentan Drug Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Ambrisentan Drug Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Ambrisentan Drug Consumption and Growth Rate (2017-2022)

    • Table Africa Ambrisentan Drug Consumption by Country (2017-2022)

    • Figure Nigeria Ambrisentan Drug Consumption and Growth Rate (2017-2022)

    • Figure South Africa Ambrisentan Drug Consumption and Growth Rate (2017-2022)

    • Figure Egypt Ambrisentan Drug Consumption and Growth Rate (2017-2022)

    • Figure Algeria Ambrisentan Drug Consumption and Growth Rate (2017-2022)

    • Table Oceania Ambrisentan Drug Consumption by Country (2017-2022)

    • Figure Australia Ambrisentan Drug Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Ambrisentan Drug Consumption and Growth Rate (2017-2022)

    • Table Sigmapharm Laboratories, LLC (United States) Company Details

    • Table Sigmapharm Laboratories, LLC (United States) Ambrisentan Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sigmapharm Laboratories, LLC (United States) Ambrisentan Drug Main Business and Markets Served

    • Table Sigmapharm Laboratories, LLC (United States) Ambrisentan Drug Product Portfolio

    • Table Cipla Inc (India) Company Details

    • Table Cipla Inc (India) Ambrisentan Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cipla Inc (India) Ambrisentan Drug Main Business and Markets Served

    • Table Cipla Inc (India) Ambrisentan Drug Product Portfolio

    • Table Glaxo Smith Kline Limited (United Kingdom) Company Details

    • Table Glaxo Smith Kline Limited (United Kingdom) Ambrisentan Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Glaxo Smith Kline Limited (United Kingdom) Ambrisentan Drug Main Business and Markets Served

    • Table Glaxo Smith Kline Limited (United Kingdom) Ambrisentan Drug Product Portfolio

    • Table Par Pharmaceutical, Inc (United States) Company Details

    • Table Par Pharmaceutical, Inc (United States) Ambrisentan Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Par Pharmaceutical, Inc (United States) Ambrisentan Drug Main Business and Markets Served

    • Table Par Pharmaceutical, Inc (United States) Ambrisentan Drug Product Portfolio

    • Table Gilead Sciences, Inc (United States) Company Details

    • Table Gilead Sciences, Inc (United States) Ambrisentan Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Gilead Sciences, Inc (United States) Ambrisentan Drug Main Business and Markets Served

    • Table Gilead Sciences, Inc (United States) Ambrisentan Drug Product Portfolio

    • Table Mylan SAS (United States) Company Details

    • Table Mylan SAS (United States) Ambrisentan Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mylan SAS (United States) Ambrisentan Drug Main Business and Markets Served

    • Table Mylan SAS (United States) Ambrisentan Drug Product Portfolio

    • Figure Global 5 mg Tablet Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global 10 mg Tablet Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Drug store Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ambrisentan Drug Consumption Forecast by Country (2022-2028)

    • Table North America Ambrisentan Drug Consumption Forecast by Country (2022-2028)

    • Figure United States Ambrisentan Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Ambrisentan Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Ambrisentan Drug Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Ambrisentan Drug Consumption Forecast by Country (2022-2028)

    • Figure Germany Ambrisentan Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Ambrisentan Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Ambrisentan Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Ambrisentan Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Ambrisentan Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Ambrisentan Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Ambrisentan Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Ambrisentan Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Ambrisentan Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Ambrisentan Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Ambrisentan Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Ambrisentan Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Ambrisentan Drug Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Ambrisentan Drug Consumption Forecast by Country (2022-2028)

    • Figure China Ambrisentan Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Ambrisentan Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Ambrisentan Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Ambrisentan Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Ambrisentan Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Ambrisentan Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Ambrisentan Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Ambrisentan Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Ambrisentan Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Ambrisentan Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Ambrisentan Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Ambrisentan Drug Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Ambrisentan Drug Consumption Forecast by Country (2022-2028)

    • Figure Brazil Ambrisentan Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Ambrisentan Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Ambrisentan Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Ambrisentan Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Ambrisentan Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Ambrisentan Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Ambrisentan Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Ambrisentan Drug Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Ambrisentan Drug Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Ambrisentan Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Ambrisentan Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Ambrisentan Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Ambrisentan Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Ambrisentan Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Ambrisentan Drug Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Ambrisentan Drug Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Ambrisentan Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Ambrisentan Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Ambrisentan Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Ambrisentan Drug Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Ambrisentan Drug Consumption Forecast by Country (2022-2028)

    • Figure Australia Ambrisentan Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Ambrisentan Drug Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US